)
)
Julien Fauqueuer
Head of Biological Machine Learning,
Novo Nordisk
Julien is an experienced AI Scientist and leader in Drug Discovery, passionate about modeling its complex mechanisms.
At Novo Nordisk, as Head of Biological Machine Learning, he leads a team who develop ML solutions for target and biomarker discovery. He previously worked for 9 years at BenevolentAI developing methods for Drug Discovery in NLP, OMICS and chemistry teams, including one that enabled an FDA-approved drug.
His prior ML research experience was in computer vision in different industries and in academia. He holds a PhD in Computer Science from INRIA France and co-authored over 30 academic publications and 5 patents.
Sessions
-
How Can We Make LLMs Even Better at Drug Discovery?29-Jan-2026AI In Drug Discovery Stage